ARCHIVES

Arimidex Gets Full Approval For HR+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Chemopreventive Phase I, Preclinical Studies Concept Approved

May 13, 1983

DD Should Transfer Part of Breast Cancer $$ To NIH r Peer Distribution, Broder Says

December 4, 1992

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011

Matted Lymph Nodes Can Predict Survival Rate, Spread of Disease

January 27, 2012

In Brief: CT Scanning Of The Brain Subject Of Consensus Development Conference; CCI Plans Congress Events

July 10, 1981

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000